Prevest Denpro Ltd.
Snapshot View

View in App

Prices View details >>

342.00 -6.15 ▼-1.8%

27 January 2023, 04:01:00 PM
Volume: 14,000

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.prevestdenpro.com
Market Cap 409.84 Cr.
Enterprise Value(EV) 410.50 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 11.02 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 30.98 Trailing Twelve Months Ending 2022-09
Industry PE 58.81 Trailing Twelve Months Ending 2022-09
Book Value / Share 53.40 Trailing Twelve Months Ending 2022-09
Price to Book Value 6.39 Calculated using Price: 341.45
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.20 Cr. 12,003,000 Shares
FaceValue 10
Company Profile
The company manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.77%
1 Week
-0.29%
1 Month
-6.30%
3 Month
-12.74%
6 Month
+12.37%
1 Year
-12.31%
2 Year
5 Year
10 Year

Ratios View Details >>

5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 29.72 34.02 39.13 38.13 29.07
Return on Capital Employed (%) 37.15 39.27 45.63 46.96 39.64
Return on Assets (%) 18.88 22.30 27.50 27.85 24.40

Balance Sheet View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 7 10 15 23 57 64
Non Curr. Liab. 1 2 2 2 2 0
Curr. Liab. 3 3 4 7 5 6
Minority Int.
Equity & Liab. 12 15 21 31 64 70
Non Curr. Assets 4 5 6 7 11 18
Curr. Assets 7 10 16 24 53 52
Misc. Exp. not W/O
Total Assets 12 15 21 31 64 70

Profit Loss View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 17 19 23 28 38 44
Other Income 1 0 2 1 2 3
Total Income 18 20 25 30 40 47
Total Expenditure -14 -15 -18 -19 -23 -28
PBIDT 4 4 7 10 17 19
Interest 0 0 0 0 0 0
Depreciation 0 0 0 0 -1 -1
Taxation -1 -1 -1 -2 -4 -5
Exceptional Items
PAT 2 3 5 7 12 13
Adjusted EPS 76 105 176 8 10 11

Cash Flow View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 3 5 9 7
Cash Fr. Inv. -1 -1 -1 -2 -4
Cash Fr. Finan. 0 0 0 -1 23
Net Change 1 2 4 6 26
Cash & Cash Eqvt 4 6 10 16 42

Shareholding Pattern View Details >>

4 Qtrs 2021-09 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 73.60 73.60 73.60 73.60
Public 26.40 26.40 26.40 26.40
Depository Receipts 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 18 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
We submit herewith the confirmation certificate and Details of Share Certificates Dematerialized for the period ended on December 31 2022 received from Bigshare Services Pvt. Ltd Registrar and Share Transfer Agent (RTA) of the Company as per regulation 74(5) of the SEBI (Depositors and Participants) Regulations 2018 for the quarter ended December 31 2022.
Thu, 29 Dec 2022
Closure of Trading Window
As per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2019 it is hereby intimated that the Trading Window for dealing in the securities of the Company is closed for Designated Persons and their immediate relatives effective from Sunday January 1 2023 until 48 hours after the declaration of Financial Results of the Company for the quarter ended December31 2022. The details of the Board Meeting and opening of the Trading Window shall be intimated in due course.
Mon, 26 Dec 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vimla Modi

Technical Scans View Details >>

Fri, 27 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at High Opening at High
High Decrease in 1 Month High Decrease in 1 Month

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Prevest Denpro Ltd.

What is Prevest Denpro share price?
Can I buy Prevest Denpro shares now?
What is the Market Cap of Prevest Denpro?
What are the key metrics to analyse Prevest Denpro?
What is the 52 Week High and Low of Prevest Denpro?
What is the trend of Prevest Denpro share price?